Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Lewis

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Molecular Cell|October 13, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, et al.
Nature Communications|October 14, 2018
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupChang S Chan, Saurabh V Laddha, Peter W Lewis, et al.
Cell|July 23, 2013
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumorsJoshua C Black, Amity L Manning, Capucine Van Rechem, et al.
Acta Neuropathologica|September 10, 2014
Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomasDenise Bechet, Gerrit G H Gielen, Andrey Korshunov, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Neoplasia (New York, N.Y.)|February 20, 2026
Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancerTanaya A Purohit, Joseph Gawdzik, Eric A Armstrong, et al.
Genes & Development|January 29, 2024
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
The Journal of Clinical Investigation|February 22, 2023
Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networksMabel Minji Jung, Siqi Shen, Giovanni A Botten, et al.
Nature Genetics|January 10, 2017
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomasSimon Papillon-Cavanagh, Chao Lu, Tenzin Gayden, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Molecular Cell|October 13, 2020
H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, et al.
Nature Communications|October 14, 2018
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupChang S Chan, Saurabh V Laddha, Peter W Lewis, et al.
Cell|July 23, 2013
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumorsJoshua C Black, Amity L Manning, Capucine Van Rechem, et al.
Acta Neuropathologica|September 10, 2014
Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomasDenise Bechet, Gerrit G H Gielen, Andrey Korshunov, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Neoplasia (New York, N.Y.)|February 20, 2026
Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancerTanaya A Purohit, Joseph Gawdzik, Eric A Armstrong, et al.
Genes & Development|January 29, 2024
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
The Journal of Clinical Investigation|February 22, 2023
Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networksMabel Minji Jung, Siqi Shen, Giovanni A Botten, et al.
Nature Genetics|January 10, 2017
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomasSimon Papillon-Cavanagh, Chao Lu, Tenzin Gayden, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Pageof 6